Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Mr Matsutani of HPB Supports Revised Prescription Form
January 23, 2006
- Eligibility Criteria for DPC Approved: Chuikyo
January 23, 2006
- Korosho Proposes Addition, Not Replacement of Prescription Form
January 23, 2006
- 200 More Hospitals Expected to Participate in DPC
January 23, 2006
- BUSINESS NEWS IN BRIEF
January 23, 2006
- Korosho to Eliminate Med. Institutions for Nursing Care
January 23, 2006
- New Union Opposes Banyu's Restructuring Plan
January 23, 2006
- Premiums Based on % of Referred Patients to Be Abolished
January 23, 2006
- JGPMA Wants to Talk More Freely with JPMA: Mr Yoshida
January 23, 2006
- NPhA Wants to See Single Basic Dispensing Fee
January 23, 2006
- Toho Stocks Generics of Sawai, Nichi-iko, and Kyowa Pharm.
January 23, 2006
- More Drugs to Come from Bio-ventures than Drug Firms: Prof. Morishita of AnGes MG
January 16, 2006
- Pharma Industry Invested \906.7 Bil. in R&D in FY2004
January 16, 2006
- JMA to Support IIT through Training, Information Supply
January 16, 2006
- Mr Takeda of FPMAJ Stresses Importance of Market Price Principle
January 16, 2006
- R&D NEWS IN BRIEF
January 16, 2006
- Companies Need to Develop Unique Survival Strategies of Their Own: Dr Aoki of JPMA
January 16, 2006
- Olympus, Cangen Biotechnologies to Expand Collaboration
January 16, 2006
- PFSB to Increase Size, Quality of Review Staff: Mr Fukui
January 16, 2006
- MEDICAL DEVICE NEWS IN BRIEF
January 16, 2006
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…